Split dose ATG strategy prevents grade III-IV acute GVHD and is associated with immune surrogates of GVL

Authors

• Zaid Al-Kadhimi, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA. zaid.alkadhimi@unmc.edu.
• Samuel Pirruccello, Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.
• Zartash Gul, Advocate Aurora HealthFollow
• Lori Maness-Harris, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
• Vijaya Raj Bhatt, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
• Krishna Gundabolu, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
• Jane Yuan, Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, NY, USA.
• Matthew Lunning, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
• Gregory Bociek, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
• Christopher D'Angelo, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
• Avyakta Kallam, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
• James Armitage, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
• Khansa Abdullah, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
• Angela Hunter, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
• Sarah Mccaslin, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
• Elizabeth Lyden, Division of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA.
• Lynnette Smith, Division of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA.
• Michael Callahan, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
• Kathryn Cole, Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.
• Steven Hinrichs, Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.
• James Talmadge, Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.
• Julie Vose, Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.

Recommended Citation

Al-Kadhimi Z, Pirruccello S, Gul Z, et al. Split dose ATG strategy prevents grade III-IV acute GVHD and is associated with immune surrogates of GVL. Bone Marrow Transplant. 2022;57(10):1629-1631. doi:10.1038/s41409-022-01772-w

Type

Letter

PubMed ID

35953707